309 related articles for article (PubMed ID: 11940488)
1. Do patient-related blood donors represent a threat to the safety of the blood supply?
Pereira A; Sanz C; Tàssies D; Ramírez B
Haematologica; 2002 Apr; 87(4):427-33. PubMed ID: 11940488
[TBL] [Abstract][Full Text] [Related]
2. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil.
Goncalez TT; Sabino EC; Murphy EL; Chen S; Chamone DA; McFarland W
Vox Sang; 2006 Apr; 90(3):170-6. PubMed ID: 16507016
[TBL] [Abstract][Full Text] [Related]
4. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
Aggarwal V; Prakash C; Yadav S; Chattopadhya D
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
[TBL] [Abstract][Full Text] [Related]
6. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
Diro E; Alemu S; G/Yohannes A
Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
McFarland W; Mvere D; Katzenstein D
AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
[TBL] [Abstract][Full Text] [Related]
9. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
12. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
Maresch C; Schluter PJ; Wilson AD; Sleigh A
Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
[TBL] [Abstract][Full Text] [Related]
13. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
Van der Bij AK; Coutinho RA; Van der Poel CL
Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety.
Zou S; Fujii K; Johnson S; Spencer B; Washington N; Iv EN; Musavi F; Newman B; Cable R; Rios J; Hillyer KL; Hillyer CD; Dodd RY;
Transfusion; 2006 Nov; 46(11):1997-2003. PubMed ID: 17076856
[TBL] [Abstract][Full Text] [Related]
16. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
17. Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.
Wang B; Higgins MJ; Kleinman S; Schreiber GB; Murphy EL; Glynn SA; Wright DJ; Nass CC; Chang D; Busch MP;
Transfusion; 2004 Aug; 44(8):1243-51. PubMed ID: 15265131
[TBL] [Abstract][Full Text] [Related]
18. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
[TBL] [Abstract][Full Text] [Related]
19. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
[TBL] [Abstract][Full Text] [Related]
20. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
